Logo image of 3SQ1.DE

AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) Stock Fundamental Analysis

FRA:3SQ1 - Deutsche Boerse Ag - NL0010872388 - Common Stock - Currency: EUR

5.45  +0.25 (+4.81%)

Fundamental Rating

5

Taking everything into account, 3SQ1 scores 5 out of 10 in our fundamental rating. 3SQ1 was compared to 48 industry peers in the Construction & Engineering industry. 3SQ1 has only an average score on both its financial health and profitability. 3SQ1 is valued quite expensive, but it does show an excellent growth. These ratings could make 3SQ1 a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year 3SQ1 was profitable.
The reported net income has been mixed in the past 5 years: 3SQ1 reported negative net income in multiple years.
In the past 5 years 3SQ1 always reported negative operating cash flow.
3SQ1.DE Yearly Net Income VS EBIT VS OCF VS FCF3SQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of 3SQ1 (10.36%) is better than 83.33% of its industry peers.
3SQ1's Return On Equity of 22.01% is fine compared to the rest of the industry. 3SQ1 outperforms 72.92% of its industry peers.
Looking at the Return On Invested Capital, with a value of 21.99%, 3SQ1 belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
Industry RankSector Rank
ROA 10.36%
ROE 22.01%
ROIC 21.99%
ROA(3y)-3.32%
ROA(5y)0.21%
ROE(3y)-2.63%
ROE(5y)1.39%
ROIC(3y)N/A
ROIC(5y)N/A
3SQ1.DE Yearly ROA, ROE, ROIC3SQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

3SQ1 has a Profit Margin of 5.62%. This is in the better half of the industry: 3SQ1 outperforms 60.42% of its industry peers.
In the last couple of years the Profit Margin of 3SQ1 has remained more or less at the same level.
3SQ1 has a Operating Margin of 8.44%. This is in the better half of the industry: 3SQ1 outperforms 60.42% of its industry peers.
3SQ1's Operating Margin has improved in the last couple of years.
The Gross Margin of 3SQ1 (24.08%) is worse than 75.00% of its industry peers.
3SQ1's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.44%
PM (TTM) 5.62%
GM 24.08%
OM growth 3Y37.68%
OM growth 5YN/A
PM growth 3Y-0.19%
PM growth 5YN/A
GM growth 3Y11.36%
GM growth 5YN/A
3SQ1.DE Yearly Profit, Operating, Gross Margins3SQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

6

2. Health

2.1 Basic Checks

The number of shares outstanding for 3SQ1 remains at a similar level compared to 1 year ago.
3SQ1 has more shares outstanding than it did 5 years ago.
3SQ1 has a better debt/assets ratio than last year.
3SQ1.DE Yearly Shares Outstanding3SQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
3SQ1.DE Yearly Total Debt VS Total Assets3SQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

3SQ1 has an Altman-Z score of 3.82. This indicates that 3SQ1 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.82, 3SQ1 belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
3SQ1 has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
3SQ1 has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. 3SQ1 outperforms 95.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 3.82
ROIC/WACCN/A
WACCN/A
3SQ1.DE Yearly LT Debt VS Equity VS FCF3SQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M 2M 3M 4M

2.3 Liquidity

3SQ1 has a Current Ratio of 1.81. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.81, 3SQ1 belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
3SQ1 has a Quick Ratio of 1.39. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.
3SQ1 has a better Quick ratio (1.39) than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.39
3SQ1.DE Yearly Current Assets VS Current Liabilites3SQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1233.33% over the past year.
The Earnings Per Share has been growing by 50.61% on average over the past years. This is a very strong growth
The Revenue has grown by 109.05% in the past year. This is a very strong growth!
Measured over the past years, 3SQ1 shows a very strong growth in Revenue. The Revenue has been growing by 189.00% on average per year.
EPS 1Y (TTM)1233.33%
EPS 3Y149.33%
EPS 5Y50.61%
EPS Q2Q%57.14%
Revenue 1Y (TTM)109.05%
Revenue growth 3Y189%
Revenue growth 5YN/A
Sales Q2Q%40.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, 3SQ1 will show a quite strong growth in Revenue. The Revenue will grow by 12.70% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-28.74%
Revenue Next 3Y-6.14%
Revenue Next 5Y12.7%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
3SQ1.DE Yearly Revenue VS Estimates3SQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2025 2026 2027 5M 10M 15M 20M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.63, 3SQ1 is valued correctly.
Based on the Price/Earnings ratio, 3SQ1 is valued a bit cheaper than 64.58% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.54. 3SQ1 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.63
Fwd PE N/A
3SQ1.DE Price Earnings VS Forward Price Earnings3SQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
3SQ1.DE Per share data3SQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for 3SQ1!.
Industry RankSector Rank
Dividend Yield N/A

AHT SYNGAS TECHNOLOGY NV

FRA:3SQ1 (8/5/2025, 7:00:00 PM)

5.45

+0.25 (+4.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.63M
Analysts84
Price Target22.04 (304.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-45.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.63
Fwd PE N/A
P/S 0.83
P/FCF N/A
P/OCF N/A
P/B 3.26
P/tB 3.51
EV/EBITDA N/A
EPS(TTM)0.4
EY7.34%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.54
BVpS1.67
TBVpS1.55
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 10.36%
ROE 22.01%
ROCE 31.58%
ROIC 21.99%
ROICexc 21.99%
ROICexgc 23.61%
OM 8.44%
PM (TTM) 5.62%
GM 24.08%
FCFM N/A
ROA(3y)-3.32%
ROA(5y)0.21%
ROE(3y)-2.63%
ROE(5y)1.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y155.68%
ROICexcg growth 5YN/A
ROICexc growth 3Y192.83%
ROICexc growth 5Y13.82%
OM growth 3Y37.68%
OM growth 5YN/A
PM growth 3Y-0.19%
PM growth 5YN/A
GM growth 3Y11.36%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.39
Altman-Z 3.82
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1233.33%
EPS 3Y149.33%
EPS 5Y50.61%
EPS Q2Q%57.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)109.05%
Revenue growth 3Y189%
Revenue growth 5YN/A
Sales Q2Q%40.03%
Revenue Next YearN/A
Revenue Next 2Y-28.74%
Revenue Next 3Y-6.14%
Revenue Next 5Y12.7%
EBIT growth 1Y475%
EBIT growth 3Y297.91%
EBIT growth 5Y78.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A